CN100588393C - 赛米司酮类用于治疗抑郁症的用途 - Google Patents
赛米司酮类用于治疗抑郁症的用途 Download PDFInfo
- Publication number
- CN100588393C CN100588393C CN200410093036A CN200410093036A CN100588393C CN 100588393 C CN100588393 C CN 100588393C CN 200410093036 A CN200410093036 A CN 200410093036A CN 200410093036 A CN200410093036 A CN 200410093036A CN 100588393 C CN100588393 C CN 100588393C
- Authority
- CN
- China
- Prior art keywords
- depression
- symipristone
- mifepristone
- glucocorticoid receptor
- dexamethasone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410093036A CN100588393C (zh) | 2004-12-15 | 2004-12-15 | 赛米司酮类用于治疗抑郁症的用途 |
PCT/CN2005/002194 WO2006063526A1 (fr) | 2004-12-15 | 2005-12-15 | Utilisation de la cymipristone pour le traitement de la depression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410093036A CN100588393C (zh) | 2004-12-15 | 2004-12-15 | 赛米司酮类用于治疗抑郁症的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1788720A CN1788720A (zh) | 2006-06-21 |
CN100588393C true CN100588393C (zh) | 2010-02-10 |
Family
ID=36587541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200410093036A Active CN100588393C (zh) | 2004-12-15 | 2004-12-15 | 赛米司酮类用于治疗抑郁症的用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN100588393C (zh) |
WO (1) | WO2006063526A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110590B (zh) * | 2009-12-29 | 2015-07-01 | 上海中西制药有限公司 | 赛米司酮固体制剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1187053C (zh) * | 1997-10-06 | 2005-02-02 | 利兰·斯坦福青年大学托管委员会 | 糖皮质素受体拮抗剂用于制造治疗精神病药物的用途 |
CN1117759C (zh) * | 1999-09-02 | 2003-08-13 | 上海中西药业股份有限公司 | 甾体化合物,其制备方法和其药物组合物及其应用 |
-
2004
- 2004-12-15 CN CN200410093036A patent/CN100588393C/zh active Active
-
2005
- 2005-12-15 WO PCT/CN2005/002194 patent/WO2006063526A1/zh not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1788720A (zh) | 2006-06-21 |
WO2006063526A1 (fr) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy | |
Roozendaal et al. | Basolateral amygdala lesions block the memory‐enhancing effect of glucocorticoid administration in the dorsal hippocampus of rats | |
Yi et al. | Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity | |
Spence et al. | Gynaecomastia associated with cimetidine. | |
Yang et al. | Involvement of estrogen receptors in silibinin protection of pancreatic β-cells from TNFα-or IL-1β-induced cytotoxicity | |
CN103582484A (zh) | 17-己酸羟孕酮(17-hpc)的肺部递送 | |
Grando | New approaches to the treatment of pemphigus | |
US20110305719A1 (en) | Inhibition of Pro-Inflammatory Cytokine Induced Response | |
Wang et al. | Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor | |
US20190314301A1 (en) | Combinations of adrenergic receptor agonists for the treatment of type 2 diabetes | |
Hsu et al. | The effects of isoliquiritigenin on endometriosis in vivo and in vitro study | |
CN1607954A (zh) | 用于治疗中枢神经系统功能紊乱的孕烷类固醇 | |
Ober | Synthetic progestagen-oestrogen preparations and endometrial morphology | |
Cheng et al. | Protective effects of hydrogen-rich water against cartilage damage in a rat model of osteoarthritis by inhibiting oxidative stress, matrix catabolism, and apoptosis | |
Long et al. | Flavonoid of Drynaria fortunei protects against acute renal failure | |
JP6626094B2 (ja) | 腎線維症を抑制するためのジンセノサイドm1の使用 | |
CN100588393C (zh) | 赛米司酮类用于治疗抑郁症的用途 | |
CN113244233A (zh) | 荜茇酰胺在制备角膜移植免疫排斥反应防治药物中的应用 | |
Koch | The biochemistry and physiological significance of the male sex hormones | |
Lee et al. | Wild ginseng attenuates repeated morphine-induced behavioral sensitization in rats | |
Pal’chikova et al. | Effects of intraperitoneal administration of mifepristone on glucocorticoid status of experimental animals | |
EP3341739A1 (en) | Mutant peptides and methods of treating subjects using the same | |
Noordam et al. | An adolescent with food-dependent Cushing's syndrome secondary to ectopic expression of GIP receptor in unilateral adrenal adenoma | |
Huang et al. | RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption | |
CN104288188B (zh) | 续断总皂苷在制备安胎药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zuo Lin Document name: Notification before expiration of term |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 201203 Shanghai city Pudong New Area Cailun Road No. 333 building D room 505 Patentee after: Shanghai Sanhe Biotech Co., Ltd. Address before: 201203, room 1043, 304 Harley Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee before: Shanghai Sanhe Biotech Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. SH Effective date: 20110829 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110829 Address after: 201203 Shanghai city Pudong New Area Cailun Road No. 333 building D room 505 Co-patentee after: Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. Patentee after: Shanghai Sanhe Biotech Co., Ltd. Co-patentee after: Zhejiang Xianju Pharmaceutical Co., Ltd. Co-patentee after: Shanghai Zhongxi Pharmaceutical Co Ltd Address before: 201203 Shanghai city Pudong New Area Cailun Road No. 333 building D room 505 Patentee before: Shanghai Sanhe Biotech Co., Ltd. |